Prevalence of peri-implant diseases among an Italian population of patients with metabolic syndrome: a cross-sectional study
Abstract
BACKGROUND
Over the years, only few authors have studied the association of systemic conditions with peri-implantitis. The aim of this study is to detect frequency and severity of peri-implant diseases among an Italian population of patients affected by metabolic syndrome (MetS).
METHODS
In this cross-sectional study, patients with at least one dental implant with >5 years of functional loading were screened to evaluate metabolic, periodontal and peri-implant status. MetS diagnosis was established in accordance with the NCEP ATP III criteria, while case definitions of the 2017 World Workshop were adopted for peri-implant diseases. For each implant, probing pocket depths, mucosal redness, bleeding on probing, suppuration, plaque index and marginal bone loss were recorded. Multinomial logistic regression analysed the relationship between gender, diagnosis of metabolic syndrome, presence of periodontitis, smoking, type of prosthesis and location of implants and peri-implant mucositis and peri-implantitis.
RESULTS
183 patients was enrolled: in MetS subjects, peri-implantitis was detected in 36.9% (n = 31) of implants, while mucositis in 60.7% (n = 51), with an OR of 10.01(p = 0.005) for mucositis and OR 15.26 (p = 0.001) for peri-implantitis, compared to subjects without MetS, where 26.3% of implants showed peri-implantitis and 55.5% mucositis. No differences were found for smoking, implant location, gender and type of prosthetic rehabilitation. Patients with periodontitis…
How strong is the evidence?
Evidence Hub reads this as a cross-sectional, done in people. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause. Reported size: 183 participants or records.
Read the paper
Related studies
- Strategy for Mitigating DKA Risk in Patients with Type 1 Diabetes on Adjunctive Treatment with SGLT Inhibitors: A STICH Protocol
- Glucoraphanin: a broccoli sprout extract that ameliorates obesity-induced inflammation and insulin resistance
- SGLT2 Inhibitors in Heart Failure: Targeted Metabolomics and Energetic Metabolism
- Mechanisms of blood pressure reduction with sodium-glucose co-transporter 2 (SGLT2) inhibitors
- Sodium-glucose cotransporter inhibitors: beyond glycaemic control
- Decoding the effects of SGLT2 inhibitors on cardiac arrhythmias in heart failure
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.